ISSN: 1017-6616 e-ISSN: 2149-8059
Home Contact Login / Sign up
-Türkçe -English
header logo
header logo
  • Home
  • Aim and Scope
  • Guide for Authors
  • Editorial Boards
  • Current Issue
  • Archive
  • Submit Article
  • Contact Us
Home Aim and Scope Guide for Authors Editorial Boards Current Issue Archive Submit Article Contact Us
kapak cover
Vol:41 Issue:2 Year:2025
Current Issue Archive Ahead of Print Copyright Notification Review Process Editorial Boards Indexing Archiving and Data Sharing Policy Open Access Policy Payment Policy Reviewer and Editor Guidelines Logo Design and Story Ethical Principles and Publication Policy Article Submission Files Contact

Search Results

EFFECTS OF VALPROATE AND CARBAMAZEPINE MONOTHERAPY ON LEUKOCYTE SUBSETS AND NEUTROPHIL-LYMPHOCYTE RATIO IN CHILDREN

SEVİM ŞAHİN

 PDF  Send an Email to Editor
INCREASED NEUTROPHIL COUNT AS A MARKER OF SYSTEMIC INFLAMMATION IN PATIENTS WITH SEBORRHEIC DERMATITIS: A RETROSPECTIVE CONTROLLED STUDY

METİN ÖZASLAN

 PDF  Send an Email to Editor
CAN NEUTROPHIL/LYMPHOCYTE RATIO BE USED AS A MARKER IN THE DIAGNOSIS OF BULLOUS PEMPHIGOID?

İLKAY ÖZER, ŞÜKRÜ BALEVİ, ARZU ATASEVEN

 PDF  Send an Email to Editor
NEUTROPHIL ERYTHROPHAGOCYTOSIS AND NEUTROPHIL ERYTHROCYTE ROSETTING IN PAROXYSMAL COLD HAEMOGLOBINURIA

HARUN PERU, MALLIKA RAJSHEKAR KALMOOD

 PDF  Send an Email to Editor
RESPIRATORY BURST IRI FLUMAN NEUTROPHILS AND NAMI OXIDASE

MUSTAFA ÜNALDI, OSMAN YILMAZ, MEHMET GÜRBİLEK, MEHMET AKÖZ, MUSTAFA YÖNTEM

 PDF  Send an Email to Editor
RESPIRATORY BURST IRI FLUMAN NEUTROPHILS AND NAMI OXIDASE

MUSTAFA ÜNALDI, OSMAN YILMAZ, MEHMET GÜRBİLEK, MEHMET AKÖZ, MUSTAFA YÖNTEM

 PDF  Send an Email to Editor
footer logo
Selçuk Tıp Dergisi

bilgi@neuyayin.com
ISSN: 1017-6616
e-ISSN: 2149-8059

Site content (images, text and applications) cannot be used without citing the source. This site has been prepared to provide information in the published content areas. When using the information on the site, the responsibility lies entirely with the user. By entering the site, you are deemed to have read, understood and accepted these terms.

This system was prepared by Dijider.